Morphine/Opiates Screen

A urine screen that comes back positive for opiates can't establish whether the source was heroin, codeine cough medicine, a morphine prescription, or poppy seed food. Some unrelated medicines can also trigger a positive. To interpret your result, you need to know what this screen detects, what it misses, and how timing affects it.

This is an established screening method used in pain management and addiction care. It gives a preliminary positive or negative result. Unexpected findings and results with serious medical, employment, or legal consequences need more specific testing.

What the Screen Looks For

Opiates include morphine and codeine, which come from the opium poppy. Heroin is made from morphine. Opioids are the wider drug family, including chemically modified drugs such as oxycodone and fully synthetic drugs such as fentanyl and methadone.

This urine screen uses an immunoassay. That method uses antibodies that react with morphine, codeine, and some related compounds. The result is qualitative: positive or negative, without a drug concentration to track. Different assays use different reporting cutoffs and react differently to related substances.

Oxycodone and oxymorphone are poorly detected by standard morphine-based screens. Hydrocodone and hydromorphone may be detected, but sensitivity varies and negative results can occur despite exposure. Fentanyl, methadone, and buprenorphine require separate tests. A negative result on this screen therefore leaves several commonly used opioids unassessed.

Where a Positive Result Comes From

Your body rapidly converts heroin into 6-acetylmorphine and then morphine. Confirmed 6-acetylmorphine in urine is specific evidence of heroin exposure. This compound has a short detection window, so its absence doesn't rule out heroin.

Morphine in urine can come from heroin, prescribed morphine, codeine, or poppy seeds. Your body converts some codeine into morphine, and the proportion varies between people and over time. In a controlled codeine study, urine morphine exceeded codeine in later samples from some participants. These were quantitative urine measurements; the ratio between the two cannot reliably identify the original drug by itself.

Poppy seed foods can contain morphine and codeine. Confirmation can establish that these compounds are present, but finding them doesn't always distinguish food from medication or heroin. Thebaine is another poppy compound that can support a dietary explanation when measured. It cannot establish that food was the only source of exposure.

Some heroin exposures produce little detectable morphine. In a study of urine samples from people receiving treatment for drug dependence, some samples contained 6-acetylmorphine despite a negative total-opiate screen. A morphine-based screen alone can therefore miss heroin use.

A positive result also leaves possible co-exposures unresolved. In one study of morphine-positive workplace specimens, separate testing found fentanyl more often than 6-acetylmorphine. Fentanyl can be prescribed or obtained illicitly, so its presence still needs the medication history.

How Long Exposure Stays Visible

Urine detection usually lasts longer than the drug's effects. Morphine and codeine are often detectable for about one to three days, but dose, repeated use, kidney function, urine concentration, and the assay's sensitivity all affect that window. These are approximate detection periods, not a way to date a dose.

The longer detection period came from a selected treatment population and isn't a schedule that applies to everyone. A positive several days after stopping can reflect earlier use. A negative several days after a single exposure may reflect clearance.

When Results Can Be Misleading

A positive screen remains provisional. In one national reference laboratory study, about a third of positive opiate screens were not confirmed. That figure describes the assays and specimens in that study; it isn't the false-positive rate for every opiate screen.

• Medication interference: certain quinolone antibiotics, including levofloxacin and ofloxacin, have caused false-positive opiate screens. A case report also described interference after a diphenhydramine overdose. These findings depend on the assay and don't mean ordinary antihistamine doses commonly cause positive results.
• Poppy seed food: food can produce genuine urinary morphine or codeine without prescription or illicit drug use. Controlled studies have documented positive results after poppy seed ingestion. Sensitive quantitative testing in a small pastry study detected traces for up to 108 hours; that does not mean a routine immunoassay would remain positive for that entire period.
• Urine dilution: fluid intake and urine concentration can affect whether a screen detects an exposure. Urine creatinine and specific gravity can help identify a dilute specimen. Dilution alone does not establish deliberate tampering.
• Incomplete drug coverage: fentanyl, methadone, buprenorphine, and some other opioids may be present despite a negative standard opiate screen. A broad panel is useful only if it includes the substances relevant to the situation.
• Overinterpreting the result: a positive screen cannot establish the dose taken, the exact time of use, impairment, or opioid use disorder. A result that matches a prescription also cannot prove that every dose was taken as directed.

Overdose Risk

Overdose risk depends on the drug, dose, tolerance, other substances taken, and medical circumstances. This urine screen doesn't measure those factors. The risk studies below used prescription records or reported opioid use, rather than positivity on this test.

Researchers compare prescription opioid doses using morphine milligram equivalents. This scale expresses the estimated potency of different opioids relative to morphine. In observational studies summarized by the CDC, prescribed doses of 50 to under 100 morphine milligram equivalents per day were associated with about two to five times the overdose risk seen at doses of 1 to under 20.

At prescribed doses of 100 or more morphine milligram equivalents per day, the association was about two to nine times the risk in that lower-dose group. These comparisons do not identify a dose with no risk. The CDC's 2022 guideline calls for individualized decisions and does not treat its dosage guideposts as rigid limits.

Combining opioids with benzodiazepines or other sedating substances can increase overdose risk. Illicit fentanyl also creates risk that this screen can miss entirely. Neither a positive nor a negative opiate result establishes whether someone is currently overdosing.

Heart and Blood Vessels

Studies of longer-term opioid use have found cardiovascular associations, but they did not establish a relationship between this urine result and future heart disease. In a large US cohort, prescription opioid use was associated with cardiovascular death, while the findings for coronary disease differed between women and men. There was no clear association with stroke in the full cohort.

A nationwide Korean study linked opioid prescriptions with more major cardiovascular events and cardiovascular deaths. Among Danes with a first heart attack, current opioid use before admission was associated with greater mortality during the following year.

These were observational studies. Pain, underlying illness, smoking, and other differences between people who do and don't take opioids can influence the findings. They do not establish that a positive urine screen predicts cardiovascular disease or that opioids caused every observed difference.

Death From Any Cause

Among nearly half a million UK Biobank participants, reported regular opioid use was more common in lower-income groups and was associated with higher mortality. A separate pooled analysis of people prescribed opioids for chronic noncancer pain found about 29 deaths per 1,000 people followed for a year. The contributing studies varied greatly, and that figure includes deaths from all causes. It is neither the number of deaths caused by opioids nor an estimate of your personal risk.

People using opioids outside medical care also have excess mortality from causes beyond overdose. This evidence concerns patterns of opioid use and the circumstances surrounding them. An isolated positive screen cannot establish that someone belongs to those studied populations.

Cancer

A 2025 study linked reported regular pharmaceutical opioid use with a group of cancers previously associated with opium, but not with the remaining cancers considered together. A companion analysis using genetic data supported a possible causal relationship. That approach adds evidence, though it depends on assumptions about what the genetic differences represent.

A matched study of people with chronic pain also found more cancer among those receiving long-term opioids. A systematic review found uneven results across drugs, cancer sites, and study designs. These findings concern sustained exposure, and they do not provide a cancer-risk interpretation for a positive urine screen.

Tracking Results Over Time

A series of results can help document whether the drugs covered by the tests were detected on collection days. This screen has no numerical level to trend. Repeated negative results cannot establish abstinence between collections or exclude opioids that require separate assays.

Quantitative confirmation can provide additional information, but even measured concentrations are affected by timing, metabolism, and urine dilution. Adjusting for creatinine does not make a rising or falling concentration a reliable measure of dose, adherence, or new use by itself.